 |
Poor
areas = poor diabetes control in children |
| |
Children and young people with diabetes living
in the most deprived areas might not manage their diabetes as well
as those from the most affluent areas, according to new research
(Diabetes UK) |
| |
|
|
Scientists
link sleep disorders to diabetes |
| |
Scientists have discovered a gene that links
type 2 diabetes and sleep disorders, according to a study of more
than 36,000 people (Guardian, UK) |
| |
|
|
Bristol-Myers
Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration
to Develop and Commercialize Dapagliflozin in Japan |
| |
The companies have been working together to
develop dapagliflozin for type 2 diabetes for nearly two years – "this inclusion of Japan was a natural progression of our collaboration and an
important strategic step in our relationship" (PharmaLive) |
| |
|
|
Update
on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy
Submission; Review May Extend into 2009 |
| |
Amylin Pharmaceuticals, Inc. Eli Lilly and Company
announced that the U.S. Food and Drug Administration is continuing
with its review of the regulatory application for use of BYETTA® (exenatide) injection as stand-alone therapy (monotherapy) in people with type
2 diabetes who are not achieving acceptable blood sugar control
(BioSpace) |
| |
|
|
deCODE
to Integrate New Genetic Risk Factor for Type 2 Diabetes Into
Its deCODEme(TM) Personal Genome Scan Service |
| |
deCODE genetics inc com today announced the
discovery by an international consortium of scientists from deCODE
and major European and US academic institutions of a single letter
variation in the human genome (SNP) that is associated with increased
fasting glucose levels and risk of type 2 diabetes (MarketWatch) |
| |
|
